{"id":"https://openalex.org/W7219349997","doi":null,"title":"BIOMARKER-BASED PREDICTION OF THE EFFECTIVENESS OF TREATMENT WITH TNF ANTAGONISTS IN RHEUMATOID ARTHRITIS","display_name":"BIOMARKER-BASED PREDICTION OF THE EFFECTIVENESS OF TREATMENT WITH TNF ANTAGONISTS IN RHEUMATOID ARTHRITIS","publication_year":2025,"publication_date":"2025-05-25","ids":{"openalex":"https://openalex.org/W7219349997"},"language":"en","primary_location":{"id":"pmh:oai:scholarexpress.net:article/5220","doi":null,"is_oa":true,"landing_page_url":"https://scholarexpress.net/index.php/index/article/view/5220","pdf_url":null,"source":{"id":"https://openalex.org/S7407065878","display_name":"World Bulletin of Public Health","issn_l":"2749-3644","issn":["2749-3644"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2749-3644","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://scholarexpress.net/index.php/index/article/view/5220","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093994937","display_name":"Norbo\u2018toyev Olimjon Mustafaqul o\u2018g\u2018li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norbo'toyev Olimjon Mustafaqul o'g'li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5122981982","display_name":"Mirzayev Ozod Voxidovich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mirzayev Ozod Voxidovich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":1.0},{"id":"https://openalex.org/keywords/tnf-antagonists","display_name":"TNF antagonists","score":0.925000011920929},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.8140000104904175},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.8640000224113464},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.8130000233650208},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":1.0},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9810000061988831},{"id":"https://openalex.org/keywords/erythrocyte-sedimentation-rate","display_name":"erythrocyte sedimentation rate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rheumatoid-factor","display_name":"rheumatoid factor","score":1.0},{"id":"https://openalex.org/keywords/anti-ccp-antibodies","display_name":"anti-CCP antibodies","score":0.996999979019165},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.7089999914169312},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.9063000082969666},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8773999810218811},{"id":"https://openalex.org/C2778143017","wikidata":"https://www.wikidata.org/wiki/Q111208","display_name":"Erythrocyte sedimentation rate","level":2,"score":0.7084000110626221},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5389999747276306},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4668000042438507},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.43630000948905945},{"id":"https://openalex.org/C2776232647","wikidata":"https://www.wikidata.org/wiki/Q702883","display_name":"Rheumatoid factor","level":3,"score":0.4219000041484833},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.41609999537467957},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3919999897480011},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.38659998774528503},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3801000118255615},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.36250001192092896},{"id":"https://openalex.org/C2909063479","wikidata":"https://www.wikidata.org/wiki/Q810254","display_name":"Antirheumatic Agents","level":3,"score":0.36239999532699585},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.35010001063346863},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.3431999981403351},{"id":"https://openalex.org/C2908701176","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biological drugs","level":3,"score":0.34130001068115234},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.33719998598098755},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32420000433921814},{"id":"https://openalex.org/C2776821229","wikidata":"https://www.wikidata.org/wiki/Q16965166","display_name":"Inflammatory arthritis","level":3,"score":0.3158999979496002},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31520000100135803},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.295199990272522},{"id":"https://openalex.org/C3020084786","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor \u03b1","level":3,"score":0.2831000089645386},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2578999996185303},{"id":"https://openalex.org/C149172746","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Efficacy","level":3,"score":0.25780001282691956},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.2549999952316284}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:scholarexpress.net:article/5220","doi":null,"is_oa":true,"landing_page_url":"https://scholarexpress.net/index.php/index/article/view/5220","pdf_url":null,"source":{"id":"https://openalex.org/S7407065878","display_name":"World Bulletin of Public Health","issn_l":"2749-3644","issn":["2749-3644"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2749-3644","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:scholarexpress.net:article/5220","doi":null,"is_oa":true,"landing_page_url":"https://scholarexpress.net/index.php/index/article/view/5220","pdf_url":null,"source":{"id":"https://openalex.org/S7407065878","display_name":"World Bulletin of Public Health","issn_l":"2749-3644","issn":["2749-3644"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2749-3644","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W156563279","https://openalex.org/W4310747330","https://openalex.org/W2142165059","https://openalex.org/W4405198489","https://openalex.org/W2936689909","https://openalex.org/W2411098472","https://openalex.org/W2161726277","https://openalex.org/W4210586123","https://openalex.org/W7214641976","https://openalex.org/W2217616236"],"abstract_inverted_index":{"This":[0],"analytical":[1],"paper":[2],"explores":[3],"how":[4,12],"laboratory":[5],"biomarkers":[6,66,102],"can":[7,141],"be":[8],"used":[9],"to":[10,20,60,93,114],"predict":[11],"patients":[13],"with":[14,39,123],"rheumatoid":[15,75],"arthritis":[16,27],"(RA)":[17],"will":[18],"respond":[19],"anti-TNF":[21],"(anti\u2013tumor":[22],"necrosis":[23],"factor)":[24],"therapy.":[25],"Rheumatoid":[26],"is":[28],"a":[29,82],"long-term":[30],"autoimmune":[31],"disorder":[32],"marked":[33],"by":[34],"chronic":[35],"inflammation,":[36],"often":[37],"associated":[38],"elevated":[40],"TNF-alpha":[41],"levels.":[42],"Biologic":[43],"anti-inflammatory":[44],"medications\u2014such":[45],"as":[46,104,106],"infliximab,":[47],"adalimumab,":[48],"and":[49,53,78,97,152],"etanercept\u2014help":[50],"reduce":[51,153],"inflammation":[52],"slow":[54],"disease":[55],"progression.":[56],"However,":[57],"individual":[58],"responses":[59],"these":[61],"treatments":[62],"vary":[63],"significantly.":[64],"Therefore,":[65],"like":[67],"C-reactive":[68],"protein":[69],"(CRP),":[70],"erythrocyte":[71],"sedimentation":[72],"rate":[73],"(ESR),":[74],"factor":[76],"(RF),":[77],"anti-CCP":[79],"antibodies":[80],"play":[81],"key":[83],"role":[84],"in":[85],"predicting":[86],"treatment":[87,129,145],"outcomes.":[88],"Future":[89],"studies":[90,136],"should":[91],"aim":[92],"further":[94],"explore,":[95],"validate,":[96],"integrate":[98],"the":[99],"most":[100],"promising":[101],"discussed,":[103],"well":[105],"identify":[107],"new":[108],"potential":[109],"indicators.":[110],"Researchers":[111],"are":[112],"encouraged":[113],"focus":[115],"on":[116],"clinical":[117],"scenarios":[118],"where":[119],"predictive":[120],"models,":[121],"even":[122],"limited":[124],"accuracy,":[125],"could":[126],"meaningfully":[127],"guide":[128],"decisions.":[130],"A":[131],"comprehensive":[132],"review":[133],"of":[134],"current":[135],"suggests":[137],"that":[138],"biomarker-based":[139],"prediction":[140],"support":[142],"more":[143],"personalized":[144],"approaches,":[146],"help":[147],"avoid":[148],"unnecessary":[149],"drug":[150],"exposure,":[151],"overall":[154],"healthcare":[155],"costs.":[156]},"counts_by_year":[],"updated_date":"2026-10-05T09:50:58.205359","created_date":"2026-10-04T00:00:00"}